Recent Posts
Archives
IRD Invest March 2022 - Openpay
IRD Invest March 2022 - "Project: 2025"
Watch the replay of Openpay's CEO (Australia & New Zealand) Dion Appel.
IRD Invest March 2022 - Oventus
IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Oventus CEO John Cox's presentation.
IRD Invest March 2022 - Pureprofile
IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Pureprofile CEO Martin Filz's presentation.
Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
CEO in focus - Pureprofile's Martin Filz
UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)
Servatus launches new trial into the effects of live biotherapeutics on insomnia
Servatus launches new trial into the effects of live biotherapeutics on insomnia, we talk to CEO Dr Wayne Finlayson to discuss this exciting initiative.
Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer
Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)
Recent client coverage highlights
Project: 2025
Join us on Thurs 31 March for "IRD Invest - Project 2025"
As we look to accelerate the integration of advanced technology over the next three years, our fourth IRD Invest conference considers some of the benefits this change will bring, for businesses and society.
We are delighted to showcase a select number of emerging ASX listed tech companies on 31 March. The free virtual event will focus on companies that are paving the way forward with major advances in technology and innovation.
XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference
XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference
Interview with Ben Fogarty, CEO (UK) XPON
We speak to Ben Fogarty, CEO (UK & Europe) from XPON Technologies Group (see video below) about what the future holds for them and the impact of the upcoming ‘Metaverse’.
Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference
A groundbreaking approach to cancer treatment
A number of breakthrough discoveries for Race Oncology's (ASX:RAC) drug Zantrene® over the past 18 months has seen the company evolve its strategy and clinical programs in order to maximise these opportunities. What does the future for Race look like?
Island Pharmaceuticals discuss the Dengue Fever pandemic
Dengue fever is a massive pandemic that continues to spread beyond geographical limits, with 400 million people affected each year. Island Pharmaceuticals (ASX: ILA) is at the forefront of the battle. Here, CEO David Foster talks about the issue:
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
IR Department celebrates International Women's Day 2022
IR Department celebrates International Women's Day 2022
Today is International Women’s Day #IWD2022 – a day that shines a spotlight on how we can strive for a world that’s more diverse, equitable and inclusive. It’s a day that recognises the achievements of women, and a world where difference is valued and celebrated!
In recognition of the day, we spoke to some of the inspiring women we work with and invited them to share their views on how we can all take action for a gender equal world in order to #BreakTheBias.
You can find out more about International Women’s Day by visiting https://www.internationalwomensday.com
- 1